CAPS Medical (Formerly “Plasmed”) Wins First Place at Israel Technology Transfer Organization’s Pitch Competition

CAPS Medical (formerly Plasmed), a MEDX Xelerator portfolio company, won first place at a pitch competition at “ITTN,” Israel’s Technology Transfer Organization’s biennial conference, on October 22, 2018. Dr. Jacob Cohen, CAPS Medical’s co-founder, presented their unique technology for selective cancer ablation using cold atmospheric plasma at ITTN’s Life Sciences track. The technology was originally developed jointly by RAMBAM Healthcare Campus and the plasma lab at the Technion, Israel Institute of Technology. It recently received seed funding from MEDX Xelerator.

Dr. Jacob Cohen pitching CAPS Medical at ITTN


This website uses cookies

We use cookies to enhance your experience on our site. Visit our Privacy Policy and Terms and Conditions of Use to learn more. By using our site, you agree to our use of cookies.

Agree | Learn More
Subscribe to Newsletter